CR Rate by Patient Characteristics
Patient Characteristics . | N . | % . |
---|---|---|
Age | ||
<55 (n = 60) | 42 | 70% |
≥55 (n = 14) | 9 | 64% |
Sex | ||
Male (n = 43) | 28 | 65% |
Female (n = 31) | 23 | 74% |
Race | ||
White (n = 67) | 46 | 69% |
Other (n = 7) | 5 | 71% |
Performance status | ||
0 (n = 45) | 32 | 71% |
1 (n = 29) | 19 | 66% |
B-symptoms | ||
Yes (n = 29) | 18 | 62% |
No (n = 43) | 32 | 74% |
Missing (n = 2) | 1 | |
Stage | ||
II (n = 13) | 8 | 62% |
III/IV (n = 61) | 43 | 70% |
International index | ||
0-1 (n = 29) | 20 | 69% |
2-4 (n = 39) | 26 | 67% |
Missing (n = 6) | 5 | |
Age adjusted international index | ||
0-1 (n = 37) | 25 | 68% |
2 (n = 31) | 21 | 68% |
Missing (n = 6) | 5 | |
Pathology | ||
Follicular large cell (n = 10) | 7 | 70% |
Diffuse small cleaved (n = 1) | 0 | 0% |
Diffuse mixed (n = 6) | 4 | 67% |
Diffuse large cell (n = 37) | 25 | 68% |
Large cell immunoblastic (n = 17) | 13 | 76% |
Composite (n = 1) | 1 | 100% |
Other (Ki-1 anaplastic) (n = 2) | 1 | 50% |
Patient Characteristics . | N . | % . |
---|---|---|
Age | ||
<55 (n = 60) | 42 | 70% |
≥55 (n = 14) | 9 | 64% |
Sex | ||
Male (n = 43) | 28 | 65% |
Female (n = 31) | 23 | 74% |
Race | ||
White (n = 67) | 46 | 69% |
Other (n = 7) | 5 | 71% |
Performance status | ||
0 (n = 45) | 32 | 71% |
1 (n = 29) | 19 | 66% |
B-symptoms | ||
Yes (n = 29) | 18 | 62% |
No (n = 43) | 32 | 74% |
Missing (n = 2) | 1 | |
Stage | ||
II (n = 13) | 8 | 62% |
III/IV (n = 61) | 43 | 70% |
International index | ||
0-1 (n = 29) | 20 | 69% |
2-4 (n = 39) | 26 | 67% |
Missing (n = 6) | 5 | |
Age adjusted international index | ||
0-1 (n = 37) | 25 | 68% |
2 (n = 31) | 21 | 68% |
Missing (n = 6) | 5 | |
Pathology | ||
Follicular large cell (n = 10) | 7 | 70% |
Diffuse small cleaved (n = 1) | 0 | 0% |
Diffuse mixed (n = 6) | 4 | 67% |
Diffuse large cell (n = 37) | 25 | 68% |
Large cell immunoblastic (n = 17) | 13 | 76% |
Composite (n = 1) | 1 | 100% |
Other (Ki-1 anaplastic) (n = 2) | 1 | 50% |